ENDRA Life Sciences- Warrants (12/05/2022) Long Term Debt

As of the most recent data (June 2026), NDRAW shows a long-term debt of $290K. That compares with $430K in the prior-year period — down 32.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NDRAW's long-term debt is now $290K (was $430K) — a 32.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether ENDRA Life Sciences- Warrants (12/05/2022) is outperforming or lagging.

Tracking NDRAW's long-term debt over time shows whether ENDRA Life Sciences- Warrants (12/05/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $290K That compares with $430K in the prior-year period — down 32.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has ENDRA Life Sciences- Warrants (12/05/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $290K) with ownership activity and broader fundamentals.

ENDRA Life Sciences- Warrants (12/05/2022)'s long-term debt is $290K; compare it with other Technology names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.